Recombinant fosfor-MEK1 (Thr292) Monoklonale antilichamen

MEK1 and MEK2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation. Activation of MEK1 and MEK2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines and also by membrane depolarization and calcium influx. Constitutively active forms of MEK1/2 are sufficient for the transformation of NIH/3T3 cells or the differentiation of PC-12 cells. MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites located within the activation loop of kinase subdomain VIII.

Phospho-MEK1 (Thr292)

Q02750

Human

Peptide. This information is proprietary to PTMab.

MEK; MKK; CFC; MAPKK; PRKMK; MAP2K; CFC3; MAPKK1; MEK1; MKK1; PRKMK1; MAP2K1; Dual specificity mitogen activated protein kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 1; ERK activator kinase 1; kinase 1; MAP kinase kinase 1; MAP kinase/Erk kinase 1; MAPK/ERK kinase 1; MAPKK 1; MEK 1; MEKK1; Mitogen activated protein kinase kinase 1; MKK 1; MP2K1; Protein kinase mitogen activated; Protein kinase mitogen activated kinase 1 (MAP kinase kinase 1)

A821

Unconjugated

WB

Signal Transduction

Protein A purified

1 mg/mL

WB 1:1000

PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Ice bag

Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

https://789.bio/eb/bHjf07fd

43 kDa

43 kDa

IgG, κ